The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats

Stroke

Volumn 28, Issue 9, 1997, Pages 1821-1829

  MacLeod, Andrew B ^a   Vasdev, Sudesh ^a   Smeda, John S ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Aldosterone; Angiotensins; Captopril; Cerebral hemorrhage; Rats

Indexed keywords

ALDOSTERONE; CAPTOPRIL; DEOXYCORTICOSTERONE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030864577     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.9.1821     Document Type: Article

References (30)

1. Gahnem F, von Lutterotti N, Camargo MJF, Laragh JH, Sealey JE. Angiotensinogen dependency of blood pressure in two high-renin hypertensive rat models. Am J Hypertens. 1994;7:899-904.
2. + feeding in stroke-prone hypertensive rats. Hypertension. 1990;15:318-326.
3. Camargo MJF, von Lutterotti N, Pecker MS, James GD, Timmermans PBMWM, Laragh JH. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens. 1991;4(suppl):341S-345S.
4. Hübner N, Kieutz R, Takahashi S, Ganten D, Lindpaintner K. Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats: a study of cause and effect. Hypertension. 1995;26:279-284.
5. Stier CT Jr, Chander P, Gutstein WH, Levine S, Itskovitz HD. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens. 1991;4:680-687.
6. Kim S, Tokuyama M, Hosoi M, Yamamoto K. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats. Hypertension. 1992;20:280-291.
7. Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol. 1979;236:H409-H416.
8. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K. Genetic predisposition to stroke in spontaneously hypertensive rats. Am J Physiol. 1976;230:1354-1359.
9. Stier CT Jr, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskovitz HD. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension. 1989;13:115-121.
10. Camargo MJF, von Lutterotti N, Campbell WG Jr, Pecker MS, James GD, Timmermans PB, Laragh JH. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens. 1993;11:31-40.
11. Inada Y, Ojima M, Itoh K, Shino A, Nishikawa K. Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Drugs Exp Clin Res. 1995;21:41-49.
12. Lee RM, Wang H, Smeda JS. Effects of perindopril on hypertension and stroke prevention in experimental animals. Can J Cardiol. 1994;10(suppl D):33D-36D.
13. Stier CT Jr, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens. 1991;11(suppl 3):S37-S42.
14. Okamoto K, Ohta Y, Chikugo T, Shiokawa H, Morita N. Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats. J Hypertens. 1991;9:1105-1117.
15. Kim S, Hosoi M, Shimamoto K, Takada T, Yamamoto K. Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension. Biochem Biophys Res Comm. 1991;178:151-157.
16. Smeda JS. Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American, Japanese-style diet. Stroke. 1989;20:1212-1218.
17. Smeda JS. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol. 1992;70:552-564.
18. Fujiwara T, Yuasa H, Ogiku N, Kawai Y. Histopathological investigation on salt loaded stroke-prone spontaneously hypertensive rats, whose biochemical parameters of renal dysfunction were ameliorated by administration of imidapril. Jpn J Pharmacol. 1994;66: 231-240.
19. Barlet-Bas C, Doucet A. Genomic effects of aldosterone on the kidney. In: Wheling M, ed. Genomic and Non-Genomic Effects of Aldosterone. Boca Raton, Fla: CRC Press Inc; 1995:17-50.
20. Wheling M. Rapid effects of aldosterone: a novel concept of non-genomic steroid action evolves. In: Wheling M, ed. Genomic and Non-Genomic Effects of Aldosterone. Boca Raton, Fla: CRC Press Inc; 1995:109-149.
21. Irish JM, Stitzel RE. Water, electrolyte metabolism and diuretic drugs. In: Craig CR, Stitzel RE, eds. Modem Pharmacology. Boston, Mass: Little Brown and Co; 1986:270-296.
22. Wehling M. Aldosterone-specific membrane receptors and related rapid, nongenomic effects. Trends Pharmacol Sci. 1993;12:141-147.
23. Wehling M. Aldosterone specific membrane receptors, rapid activation of the sodium-hydrogen exchanger and cardiovascular implications. Cardiovasc Res. 1995;29:167-171.
24. Christ M, Meyer C, Sippel K, Wehling M. Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C α. Biochem Biophys Res Comm. 1995;213:123-129.
25. Wehling M, Ulsenheimer A, Schneider M, Neylon C, Christ M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging. Biochem Biophys Res Comm. 1994;204:475-481.
26. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension. 1995;25:117-123.
27. Wehling M, Kasmayr J, Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway. Am J Physiol. 1991;260:E719-E726.
28. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial muscle. Am J Physiol. 1995;268: C799-C822.
29. Osol G, Laher I, Cippolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res. 1991;68:359-367.
30. Copeman L, MacLeod A, Smeda JS. The effect of captopril treatment on the cerebrovasculature of Kyoto Wistar stroke prone hypertensive rats. FASEB J. 1996;10(3):3648. Abstract.